Affinage

MIER3

Mesoderm induction early response protein 3 · UniProt Q7Z3K6

Length
550 aa
Mass
61.4 kDa
Annotated
2026-06-10
12 papers in source corpus 4 papers cited in narrative 6 extracted findings
Cross-family judge faithfulness: 3/5 claims corpus-supported (60%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

MIER3 is a predominantly nuclear ELM2-SANT family protein implicated in transcriptional repression and the control of epithelial-mesenchymal transition (EMT) in cancer (PMID:28046085, PMID:28887525). Unlike its paralogs MIER1 and MIER2, MIER3 does not constitutively recruit HDAC1 or HDAC2 and its complexes carry no associated deacetylase activity in HEK293, MCF7, and HeLa cells, nor does it homodimerize or heterodimerize with other MIER family members (PMID:28046085). In a breast cancer context, MIER3 assembles a co-repressor complex with HDAC1, HDAC2, and Snail that binds the E-cadherin promoter and drives its histone-deacetylation-dependent silencing, promoting EMT (PMID:34242623). In colorectal cancer, MIER3 instead acts as a tumor suppressor, inhibiting proliferation, migration, invasion, and xenograft growth and metastasis through reduction of Sp1 protein levels and consequent suppression of EMT (PMID:28887525). In non-small-cell lung cancer, MIER3 overexpression suppresses proliferation and invasion, inhibits Wnt/β-catenin signaling, and decreases the histone acetyltransferase activity of p300 (PMID:35117188). The opposing co-repressor and tumor-suppressor roles reported across tissue contexts are not reconciled mechanistically in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 2017 Medium

    Establishing where MIER3 acts and whether it shares the HDAC-recruiting co-repressor activity of its paralogs was needed to place it within the MIER family; the data localized it to the nucleus but showed it diverges functionally from MIER1/MIER2.

    Evidence Confocal immunofluorescence, Co-IP, and HDAC activity assays across HEK293, MCF7, and HeLa cells

    PMID:28046085

    Open questions at the time
    • No identification of which transcriptional partners or chromatin marks MIER3 does engage
    • Negative HDAC result was obtained in standard cell lines, not cancer-specific contexts
    • No functional consequence directly linked to nuclear localization
  2. 2017 Medium

    Whether MIER3 influences tumor behavior was unknown; gain-of-function experiments established it as a suppressor of colorectal cancer growth and metastasis acting through Sp1 reduction and EMT suppression.

    Evidence Proliferation, migration/invasion assays, xenograft mouse model, and Western blot of Sp1 and EMT markers

    PMID:28887525

    Open questions at the time
    • Mechanism by which MIER3 lowers Sp1 protein levels is undefined
    • No direct physical interaction with Sp1 demonstrated
    • Does not address contexts where MIER3 is oncogenic
  3. 2020 Low

    The pathway through which MIER3 restrains lung cancer was unclear; data linked it to Wnt/β-catenin inhibition and reduced p300 HAT activity, extending its tumor-suppressor role to NSCLC.

    Evidence MTT, wound-healing, Transwell, flow cytometry, HAT activity assay, and xenograft model in NSCLC cells

    PMID:35117188

    Open questions at the time
    • HAT inhibition mechanism not biochemically dissected and direct MIER3-p300 interaction not shown
    • Link between Wnt/β-catenin inhibition and p300 activity not established
    • Single-lab study
  4. 2021 Medium

    Contrary to the earlier negative HDAC result and the tumor-suppressor role, this work showed MIER3 can form an HDAC1/HDAC2/Snail co-repressor complex that silences E-cadherin to drive EMT in breast cancer, defining an oncogenic, context-dependent activity.

    Evidence Co-IP, ChIP, immunofluorescence, and Western blot in breast cancer cells

    PMID:34242623

    Open questions at the time
    • Directly contradicts the 2017 finding that MIER3 does not recruit HDAC1/2; discrepancy unresolved
    • Whether HDAC recruitment is cell-type-specific or condition-dependent is unknown
    • No structural basis for the differential complex assembly

Open questions

Synthesis pass · forward-looking unresolved questions
  • How MIER3 switches between an HDAC-recruiting oncogenic co-repressor and a Sp1/p300/Wnt-modulating tumor suppressor across tissues remains unresolved.
  • No mechanistic reconciliation of context-dependent HDAC recruitment
  • No structural or domain-level basis for partner selection
  • Direct binding partners beyond Snail/HDACs not mapped

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140110 transcription regulator activity 2
Localization
GO:0005634 nucleus 1
Pathway
R-HSA-74160 Gene expression (Transcription) 1
Partners

Evidence

Reading pass · 6 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2017 MIER3 is predominantly a nuclear protein, as determined by confocal microscopy analysis. Confocal immunofluorescence microscopy PloS one Medium 28046085
2017 MIER3 does not recruit HDAC1 or HDAC2, and MIER3 complexes have no associated deacetylase activity, in contrast to MIER1 and MIER2. This was demonstrated across HEK293, MCF7, and HeLa cell lines. Co-immunoprecipitation and histone deacetylase activity assay PloS one Medium 28046085
2017 MIER3 does not form homodimers or heterodimers with MIER1 or MIER2, as shown by co-immunoprecipitation. Co-immunoprecipitation PloS one Medium 28046085
2021 MIER3 interacts with HDAC1, HDAC2, and Snail to form a transcriptional co-repressor complex that binds the E-cadherin promoter, leading to histone deacetylation and silencing of E-cadherin, thereby promoting epithelial-mesenchymal transition (EMT) in breast cancer cells. Co-immunoprecipitation, immunofluorescence, chromatin immunoprecipitation (ChIP) assay, Western blot Experimental cell research Medium 34242623
2017 MIER3 overexpression inhibits colorectal cancer cell proliferation, migration, and invasion in vitro and represses tumor growth and metastasis in vivo, acting at least partly through reduction of Sp1 protein levels and subsequent suppression of EMT. Cell proliferation assay, migration/invasion assay, xenograft mouse model, Western blot (Sp1 and EMT markers) Scientific reports Medium 28887525
2020 MIER3 overexpression suppresses NSCLC cell proliferation, migration, and invasion, and inhibits the Wnt/β-catenin signaling pathway. Additionally, MIER3 decreases the histone acetyltransferase (HAT) activity of p300 in NSCLC cells. MTT assay, wound-healing assay, Transwell invasion assay, Western blot, flow cytometry, HAT activity assay, xenograft mouse model Translational cancer research Low 35117188

Source papers

Stage 0 corpus · 12 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2017 Differential HDAC1 and 2 Recruitment by Members of the MIER Family. PloS one 26 28046085
2017 MIER3 suppresses colorectal cancer progression by down-regulating Sp1, inhibiting epithelial-mesenchymal transition. Scientific reports 25 28887525
2012 Rat Mcs1b is concordant to the genome-wide association-identified breast cancer risk locus at human 5q11.2 and MIER3 is a candidate cancer susceptibility gene. Cancer research 22 22993404
2021 MIER3 induces epithelial-mesenchymal transition and promotes breast cancer cell aggressiveness via forming a co-repressor complex with HDAC1/HDAC2/Snail. Experimental cell research 18 34242623
2020 Characterization and functional prediction of the microRNAs differentially expressed in a mouse model of concanavalin A-induced autoimmune hepatitis. International journal of medical sciences 14 32922197
2016 Does mouse embryo primordial germ cell activation start before implantation as suggested by single-cell transcriptomics dynamics? Molecular human reproduction 14 26740066
2021 Breed Ancestry, Divergence, Admixture, and Selection Patterns of the Simbra Crossbreed. Frontiers in genetics 9 33584805
2020 MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity. Translational cancer research 5 35117188
2024 Transcriptome analysis provides insights into high fat diet-induced kidney injury and moderate intensity continuous training-mediated protective effects. Heliyon 3 38444510
2025 Identification and functional analysis of Rattus norvegicus Mammary carcinoma susceptibility 1b (Mcs1b) nominated variants. Mammalian genome : official journal of the International Mammalian Genome Society 0 40973823
2023 Preliminary Study on Expression and Function of the Chicken W Chromosome Gene MIER3 in Embryonic Gonads. International journal of molecular sciences 0 37240242
2020 Erratum to MIER3 suppresses the progression of non-small cell lung cancer by inhibiting Wnt/β-Catenin pathway and histone acetyltransferase activity. Translational cancer research 0 35129549

Missed literature

Know a paper Affinage missed for MIER3? Flag it for the maintainers and the community.

No submissions yet.